{"transactions":[{"id":1121070,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-05T20:54:13.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":55727,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 4, 2026 or (ii) the day before the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 4, 2026 or (ii) the day before the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":55727,"derivative":{"underlying":"Common Stock","underlying_shares":55727},"source":{"system":"sec-edgar","filing":"0001104659-25-056890","document":"tm2517281-1_4sseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465925056890/tm2517281-1_4sseq1.xml","form_type":"4"}},{"id":1121069,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-05T20:54:13.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":false,"shares":65335,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":65335},"source":{"system":"sec-edgar","filing":"0001104659-25-056890","document":"tm2517281-1_4sseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465925056890/tm2517281-1_4sseq1.xml","form_type":"4"}},{"id":1121068,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:54:13.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":65335,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":272994,"source":{"system":"sec-edgar","filing":"0001104659-25-056890","document":"tm2517281-1_4sseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465925056890/tm2517281-1_4sseq1.xml","form_type":"4"}},{"id":1486399,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-07T20:14:53.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65335,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 6, 2025 or (ii) the day before the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 6, 2025 or (ii) the day before the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":65335,"derivative":{"underlying":"Common Stock","underlying_shares":65335},"source":{"system":"sec-edgar","filing":"0001104659-24-069647","document":"tm2416748-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465924069647/tm2416748-1_4seq1.xml","form_type":"4"}},{"id":1486398,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-07T20:14:53.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":40178,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On June 7, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 40,178 Restricted Stock Units which vested 100% on June 5, 2024 or the day before the date of the Issuer's 2024 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On June 7, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 40,178 Restricted Stock Units which vested 100% on June 5, 2024 or the day before the date of the Issuer's 2024 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On June 7, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 40,178 Restricted Stock Units which vested 100% on June 5, 2024 or the day before the date of the Issuer's 2024 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On June 7, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 40,178 Restricted Stock Units which vested 100% on June 5, 2024 or the day before the date of the Issuer's 2024 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40178},"source":{"system":"sec-edgar","filing":"0001104659-24-069647","document":"tm2416748-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465924069647/tm2416748-1_4seq1.xml","form_type":"4"}},{"id":1486397,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:14:53.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":40178,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On June 7, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 40,178 Restricted Stock Units which vested 100% on June 5, 2024 or the day before the date of the Issuer's 2024 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":207659,"source":{"system":"sec-edgar","filing":"0001104659-24-069647","document":"tm2416748-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465924069647/tm2416748-1_4seq1.xml","form_type":"4"}},{"id":1861979,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-08T23:31:08.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":40178,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 7, 2024 or (ii) the day before the date of the Issuer's 2024 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 7, 2024 or (ii) the day before the date of the Issuer's 2024 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":40178,"derivative":{"underlying":"Common Stock","underlying_shares":40178},"source":{"system":"sec-edgar","filing":"0001104659-23-069543","document":"tm2318299-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465923069543/tm2318299-1_4seq1.xml","form_type":"4"}},{"id":1861978,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-08T23:31:08.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":false,"shares":45918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On March 28, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 45,918 Restricted Stock Units which vested 100% on June 6, 2023 or the day before the date of the Issuer's 2023 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On March 28, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 45,918 Restricted Stock Units which vested 100% on June 6, 2023 or the day before the date of the Issuer's 2023 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On March 28, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 45,918 Restricted Stock Units which vested 100% on June 6, 2023 or the day before the date of the Issuer's 2023 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On March 28, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 45,918 Restricted Stock Units which vested 100% on June 6, 2023 or the day before the date of the Issuer's 2023 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":45918},"source":{"system":"sec-edgar","filing":"0001104659-23-069543","document":"tm2318299-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465923069543/tm2318299-1_4seq1.xml","form_type":"4"}},{"id":1861977,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T23:31:08.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":true,"shares":45918,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On March 28, 2023, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 45,918 Restricted Stock Units which vested 100% on June 6, 2023 or the day before the date of the Issuer's 2023 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":167481,"source":{"system":"sec-edgar","filing":"0001104659-23-069543","document":"tm2318299-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465923069543/tm2318299-1_4seq1.xml","form_type":"4"}},{"id":1934890,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-03-31T01:00:42.000Z","date":"2023-03-28","kind":"grant","planned":false,"acquired":true,"shares":45918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F12","text":"On June 2, 2022, the Reporting Person filed a Form 4 reporting an award of 27,522 Restricted Stock Units by Robin Murray effective as of June 1, 2022. Due to Issuer administrative error, the award was not processed. In accordance with the Issuer's Non-Employee Director Compensation Policy, a copy of which is filed as Exhibit 10.9 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2022, Robin Murray is entitled to receive an award of Restricted Stock Units (RSUs) with a grant date value of $180,000. This award was processed effective as of March 28, 2023, resulting in the issuance of 45,918 RSUs to Robin Murray."},{"field":"shares","element":"transactionShares","label":"F12","text":"On June 2, 2022, the Reporting Person filed a Form 4 reporting an award of 27,522 Restricted Stock Units by Robin Murray effective as of June 1, 2022. Due to Issuer administrative error, the award was not processed. In accordance with the Issuer's Non-Employee Director Compensation Policy, a copy of which is filed as Exhibit 10.9 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2022, Robin Murray is entitled to receive an award of Restricted Stock Units (RSUs) with a grant date value of $180,000. This award was processed effective as of March 28, 2023, resulting in the issuance of 45,918 RSUs to Robin Murray."},{"field":"shares","element":"transactionShares","label":"F13","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 1, 2023 or (ii) the day before the date of the Issuer's 2023 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 1, 2023 or (ii) the day before the date of the Issuer's 2023 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F12","text":"On June 2, 2022, the Reporting Person filed a Form 4 reporting an award of 27,522 Restricted Stock Units by Robin Murray effective as of June 1, 2022. Due to Issuer administrative error, the award was not processed. In accordance with the Issuer's Non-Employee Director Compensation Policy, a copy of which is filed as Exhibit 10.9 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2022, Robin Murray is entitled to receive an award of Restricted Stock Units (RSUs) with a grant date value of $180,000. This award was processed effective as of March 28, 2023, resulting in the issuance of 45,918 RSUs to Robin Murray."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F12","text":"On June 2, 2022, the Reporting Person filed a Form 4 reporting an award of 27,522 Restricted Stock Units by Robin Murray effective as of June 1, 2022. Due to Issuer administrative error, the award was not processed. In accordance with the Issuer's Non-Employee Director Compensation Policy, a copy of which is filed as Exhibit 10.9 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2022, Robin Murray is entitled to receive an award of Restricted Stock Units (RSUs) with a grant date value of $180,000. This award was processed effective as of March 28, 2023, resulting in the issuance of 45,918 RSUs to Robin Murray."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"On June 2, 2022, the Reporting Person filed a Form 4 reporting an award of 27,522 Restricted Stock Units by Robin Murray effective as of June 1, 2022. Due to Issuer administrative error, the award was not processed. In accordance with the Issuer's Non-Employee Director Compensation Policy, a copy of which is filed as Exhibit 10.9 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2022, Robin Murray is entitled to receive an award of Restricted Stock Units (RSUs) with a grant date value of $180,000. This award was processed effective as of March 28, 2023, resulting in the issuance of 45,918 RSUs to Robin Murray."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":45918,"derivative":{"underlying":"Common Stock","underlying_shares":45918},"source":{"system":"sec-edgar","filing":"0001104659-23-039431","document":"tm2311098-1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465923039431/tm2311098-1_4a.xml","form_type":"4/A","original_submission_date":"2022-06-02"}},{"id":2185430,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T22:20:13.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to one-twelfth (1/12th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Elisha P. Gould's continued service relationship with the Issuer on each such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":0.965,"expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-091430","document":"tm2223529-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465922091430/tm2223529-1_4seq1.xml","form_type":"4"}},{"id":2244123,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T17:46:57.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":27522,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 1, 2023 or (ii) the day before the date of the Issuer's 2023 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 1, 2023 or (ii) the day before the date of the Issuer's 2023 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":27522,"derivative":{"underlying":"Common Stock","underlying_shares":27522},"source":{"system":"sec-edgar","filing":"0001104659-22-067985","document":"tm2217667-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465922067985/tm2217667-1_4seq1.xml","form_type":"4"}},{"id":2244122,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T17:46:57.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":27565,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On June 1, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,565 Restricted Stock Units which vested 100% on May 31, 2022 or the day before the date of the Issuer's 2022 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On June 1, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,565 Restricted Stock Units which vested 100% on May 31, 2022 or the day before the date of the Issuer's 2022 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On June 1, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,565 Restricted Stock Units which vested 100% on May 31, 2022 or the day before the date of the Issuer's 2022 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On June 1, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,565 Restricted Stock Units which vested 100% on May 31, 2022 or the day before the date of the Issuer's 2022 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27565},"source":{"system":"sec-edgar","filing":"0001104659-22-067985","document":"tm2217667-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465922067985/tm2217667-1_4seq1.xml","form_type":"4"}},{"id":2244121,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T17:46:57.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":27565,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On June 1, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,565 Restricted Stock Units which vested 100% on May 31, 2022 or the day before the date of the Issuer's 2022 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":121563,"source":{"system":"sec-edgar","filing":"0001104659-22-067985","document":"tm2217667-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465922067985/tm2217667-1_4seq1.xml","form_type":"4"}},{"id":2571849,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T20:02:42.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the first anniversary of the grant date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":2.6,"expiration_date":"2021-09-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-115070","document":"tm2127493-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921115070/tm2127493-1_4seq1.xml","form_type":"4"}},{"id":2617215,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":79734,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP (\"AS 2019\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":19186},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617214,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":171505,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP (\"AS 2018\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":41269},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617213,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":114843,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":27635},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617212,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":88775,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":21362},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617211,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":299003,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street Growth Equity Fund VII LP (\"AS GE VII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":71950},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617210,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":309321,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":74432},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617209,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":935985,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP (\"AS 2019\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":225229},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617208,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":2013269,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP (\"AS 2018\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":484459},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617207,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":1348119,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":324402},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617206,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":1042120,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250768},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617205,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":3509939,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street Growth Equity Fund VII LP (\"AS GE VII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":844608},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617204,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":3631066,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":873755},"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617203,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":12368,"price":15,"value":185520.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"AS 2019 acquired additional shares in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP (\"AS 2019\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":256783,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617202,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":244415,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP (\"AS 2019\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":244415,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617201,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":26604,"price":15,"value":399060.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"AS 2018 acquired additional shares in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP (\"AS 2018\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":552333,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617200,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":525729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP (\"AS 2018\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":525729,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617199,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":352037,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":352037,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617198,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":272131,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":272131,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617197,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":46381,"price":15,"value":695715.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"AS GE VII acquired additional shares in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street Growth Equity Fund VII LP (\"AS GE VII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":962939,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617196,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":916558,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street Growth Equity Fund VII LP (\"AS GE VII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":916558,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617195,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":47981,"price":15,"value":719715.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"ASVG VI acquired additional shares in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":996169,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2617194,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-03T22:24:29.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":948188,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":948188,"source":{"system":"sec-edgar","filing":"0001104659-21-099613","document":"tm2124030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921099613/tm2124030-1_4seq1.xml","form_type":"4"}},{"id":2665893,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:15:40.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":2.74,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-082015","document":"tm2119970-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921082015/tm2119970-1_4seq1.xml","form_type":"4"}},{"id":2680662,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-04T20:19:51.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":27565,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":27565,"derivative":{"underlying":"Common Stock","underlying_shares":27565},"source":{"system":"sec-edgar","filing":"0001104659-21-077037","document":"tm2118815-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921077037/tm2118815-1_4.xml","form_type":"4"}},{"id":2680661,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-04T20:19:51.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":16375,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On January 4, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 16,375 Restricted Stock Units which vested 100% on June 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On January 4, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 16,375 Restricted Stock Units which vested 100% on June 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On January 4, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 16,375 Restricted Stock Units which vested 100% on June 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On January 4, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 16,375 Restricted Stock Units which vested 100% on June 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16375},"source":{"system":"sec-edgar","filing":"0001104659-21-077037","document":"tm2118815-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921077037/tm2118815-1_4.xml","form_type":"4"}},{"id":2680660,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T20:19:51.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":16375,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On January 4, 2021, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 16,375 Restricted Stock Units which vested 100% on June 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":93998,"source":{"system":"sec-edgar","filing":"0001104659-21-077037","document":"tm2118815-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921077037/tm2118815-1_4.xml","form_type":"4"}},{"id":2794300,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T21:02:00.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":40911,"price":7.37,"value":301514.07,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by Adams Street 2009 Direct Fund, L.P. (\"AS 2009\"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2009, may be deemed to beneficially own the shares held by AS 2009. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2009. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2009 except to the extent of their pecuniary interest therein."}],"balance_after":4267067,"source":{"system":"sec-edgar","filing":"0001104659-21-034987","document":"tm219376d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921034987/tm219376d1_4.xml","form_type":"4"}},{"id":2794299,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T21:02:00.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":46695,"price":7.37,"value":344142.15,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by Adams Street 2008 Direct Fund, L.P. (\"AS 2008\"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2008, may be deemed to beneficially own the shares held by AS 2008. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2008. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2008 except to the extent of their pecuniary interest therein."}],"balance_after":4870262,"source":{"system":"sec-edgar","filing":"0001104659-21-034987","document":"tm219376d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921034987/tm219376d1_4.xml","form_type":"4"}},{"id":2794298,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T21:02:00.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":41426,"price":7.37,"value":305309.62,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by Adams Street 2007 Direct Fund, L.P. (\"AS 2007\"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2007, may be deemed to beneficially own the shares held by AS 2007. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2007. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2007 except to the extent of their pecuniary interest therein."}],"balance_after":4320786,"source":{"system":"sec-edgar","filing":"0001104659-21-034987","document":"tm219376d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921034987/tm219376d1_4.xml","form_type":"4"}},{"id":2919727,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-01-05T21:03:12.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":16375,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F15","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on June 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"100% of the Restricted Stock Units awarded will vest on June 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang , each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":16375,"derivative":{"underlying":"Common Stock","underlying_shares":16375},"source":{"system":"sec-edgar","filing":"0001104659-21-000897","document":"tm211737d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921000897/tm211737d1_4.xml","form_type":"4"}},{"id":2919726,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-01-05T21:03:12.000Z","date":"2021-01-02","kind":"exercise","acquired":false,"shares":38167,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On January 2, 2020, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 38,167 Restricted Stock Units which vested 100% on January 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On January 2, 2020, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 38,167 Restricted Stock Units which vested 100% on January 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On January 2, 2020, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 38,167 Restricted Stock Units which vested 100% on January 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On January 2, 2020, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 38,167 Restricted Stock Units which vested 100% on January 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang , each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38167},"source":{"system":"sec-edgar","filing":"0001104659-21-000897","document":"tm211737d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921000897/tm211737d1_4.xml","form_type":"4"}},{"id":2919725,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:03:12.000Z","date":"2021-01-02","kind":"exercise","acquired":true,"shares":38167,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On January 2, 2020, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 38,167 Restricted Stock Units which vested 100% on January 2, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":77623,"source":{"system":"sec-edgar","filing":"0001104659-21-000897","document":"tm211737d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465921000897/tm211737d1_4.xml","form_type":"4"}},{"id":2930295,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T16:01:23.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":1584,"price":12.32,"value":19514.88,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":1457115,"source":{"system":"sec-edgar","filing":"0001104659-20-140145","document":"tm2039509d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920140145/tm2039509d1_4.xml","form_type":"4"}},{"id":2930294,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T16:01:23.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":681,"price":12.32,"value":8389.92,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":626000,"source":{"system":"sec-edgar","filing":"0001104659-20-140145","document":"tm2039509d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920140145/tm2039509d1_4.xml","form_type":"4"}},{"id":2930293,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T16:01:23.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":455,"price":12.32,"value":5605.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":418190,"source":{"system":"sec-edgar","filing":"0001104659-20-140145","document":"tm2039509d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920140145/tm2039509d1_4.xml","form_type":"4"}},{"id":2930292,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T16:01:23.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":469,"price":12.32,"value":5778.08,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":431117,"source":{"system":"sec-edgar","filing":"0001104659-20-140145","document":"tm2039509d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920140145/tm2039509d1_4.xml","form_type":"4"}},{"id":2930291,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T16:01:23.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":611,"price":12.32,"value":7527.52,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":561634,"source":{"system":"sec-edgar","filing":"0001104659-20-140145","document":"tm2039509d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920140145/tm2039509d1_4.xml","form_type":"4"}},{"id":2931541,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:02:21.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":1905,"price":12.39,"value":23602.95,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":1458699,"source":{"system":"sec-edgar","filing":"0001104659-20-139741","document":"tm2039377d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920139741/tm2039377d1_4.xml","form_type":"4"}},{"id":2931540,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:02:21.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":819,"price":12.39,"value":10147.41,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":626681,"source":{"system":"sec-edgar","filing":"0001104659-20-139741","document":"tm2039377d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920139741/tm2039377d1_4.xml","form_type":"4"}},{"id":2931539,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:02:21.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":547,"price":12.39,"value":6777.33,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":418645,"source":{"system":"sec-edgar","filing":"0001104659-20-139741","document":"tm2039377d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920139741/tm2039377d1_4.xml","form_type":"4"}},{"id":2931538,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:02:21.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":564,"price":12.39,"value":6987.96,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":431586,"source":{"system":"sec-edgar","filing":"0001104659-20-139741","document":"tm2039377d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920139741/tm2039377d1_4.xml","form_type":"4"}},{"id":2931537,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:02:21.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":734,"price":12.39,"value":9094.26,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":562245,"source":{"system":"sec-edgar","filing":"0001104659-20-139741","document":"tm2039377d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000110465920139741/tm2039377d1_4.xml","form_type":"4"}},{"id":3016359,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T16:01:23.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":4623,"price":2.163,"value":9999.549,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":4623,"derivative":{"exercise_price":3.38,"expiration_date":"2030-09-29","underlying":"Common Stock","underlying_shares":4623},"source":{"system":"sec-edgar","filing":"0001104659-20-111684","document":"tm2032270d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920111684/tm2032270d1_4.xml","form_type":"4"}},{"id":3084381,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:05:43.000Z","date":"2020-07-09","kind":"other","acquired":true,"shares":90124,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,246 shares received by Adams Street Partnership Fund - 2002 U.S. Fund, L.P. (AS 2002 US), 18,583 shares received by Adams Street Partnership Fund - 2003 U.S. Fund, L.P. (AS 2003 US), 14,354 shares received by Adams Street Partnership Fund - 2004 U.S. Fund, L.P. (AS 2004 US), 19,995 shares received by Adams Street Partnership Fund - 2005 U.S. Fund, L.P. (AS 2005 US), 1,186 shares received by Brinson Partnership Fund - 2004 Primary Fund, L.P. (BPF 2004 Primary), 796 shares received by The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd. (BPF 2004 Offshore), 2,472 shares received by Brinson Partnership Fund Trust - 2004 Primary Fund (BPF 2004 Trust) and 12,492 shares received by The Bank of New York Mellon as Trustee for the HP Inc. Master Trust (HP Trust), in each case, for no consideration as part of an exempt pro-rata distribution of shares on July 9, 2020 by a fund controlled by a third-party manager."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 61,833 shares held by AS 2002 US, 56,753 shares held by AS 2003 US, 43,838 shares held by AS 2004 US, 61,066 shares held by AS 2005 US, 3,622 shares held by BPF 2004 Primary, 2,431 shares held by BPF 2004 Offshore, 7,550 shares held by BPF 2004 Trust and 38,151 shares held by HP Trust. All such shares were received for no consideration as part of exempt pro-rata distributions of shares by a fund controlled by a third-party manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares owned by each of AS 2002 US, AS 2003 US, AS 2004 US, AS 2005 US, BPF 2004 Primary, BPF 2004 Offshore, BPF 2004 Trust and HP Trust (the aforementioned funds, the \"Funds\") may be deemed to be beneficially owned by Adams Street Partners, LLC, the general partner of AS 2002 US, AS 2003 US, AS 2004 US and AS 2005 US; which is the sub-advisor and acts under power of attorney with respect to BPF 2004 Primary, BPF 2004 Offshore and BPF 2004 Trust; and which is the advisor and acts under power of attorney with respect to HP Trust. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":275244,"source":{"system":"sec-edgar","filing":"0001104659-20-083085","document":"tm2024585d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920083085/tm2024585d1_4.xml","form_type":"4"}},{"id":3092028,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:02:08.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":3735,"price":2.677,"value":9998.595,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":3735,"derivative":{"exercise_price":4.17,"expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":3735},"source":{"system":"sec-edgar","filing":"0001104659-20-080528","document":"tm2024050d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920080528/tm2024050d1_4.xml","form_type":"4"}},{"id":3092432,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":2237832,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":419148},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092431,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":961412,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":180072},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092430,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":642260,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":120294},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092429,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":662111,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":124013},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092428,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":862558,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":161556},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092427,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":5560341,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":1041456},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092426,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":2388822,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":447428},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092425,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":1595823,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":298898},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092424,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":1645147,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":308137},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092423,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":2143200,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":401423},"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092422,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":419148,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":1460604,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092421,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":180072,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":627500,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092420,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":120294,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":419192,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092419,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":124013,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":432150,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092418,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":161556,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":562979,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092417,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":1041456,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":1041456,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092416,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":447428,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP (\"AS 2017\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":447428,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092415,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":298898,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":298898,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092414,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":308137,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":308137,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3092413,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T16:01:56.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":401423,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the \"Funds\"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":401423,"source":{"system":"sec-edgar","filing":"0000899243-20-018254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000089924320018254/doc4.xml","form_type":"4"}},{"id":3110263,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T21:28:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":3.27,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-073458","document":"tm2022676d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465920073458/tm2022676d1_4.xml","form_type":"4"}},{"id":3120080,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-06-05T20:05:23.000Z","date":"2020-06-03","kind":"grant","acquired":false,"shares":38167,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F12","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"100% of the Restricted Stock Units awarded will vest on January 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"100% of the Restricted Stock Units awarded will vest on January 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":38167,"derivative":{"underlying":"Common Stock","underlying_shares":38167},"source":{"system":"sec-edgar","filing":"0001104659-20-070293","document":"tm2021940-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465920070293/tm2021940-1_4.xml","form_type":"4"}},{"id":3186705,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T16:01:20.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":7374,"price":1.356,"value":9999.144,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":7374,"derivative":{"exercise_price":2.16,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":7374},"source":{"system":"sec-edgar","filing":"0001104659-20-042431","document":"tm2014861d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920042431/tm2014861d1_4.xml","form_type":"4"}},{"id":3197724,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-23T20:03:15.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option vest and become exercisable on the one-year anniversary of the grant date, subject to continued service as a director through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-037295","document":"tm2013500d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465920037295/tm2013500d1_4.xml","form_type":"4"}},{"id":3270764,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T11:30:13.000Z","date":"2020-01-29","kind":"other","acquired":true,"shares":90124,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,246 shares received by Adams Street Partnership Fund - 2002 U.S. Fund, L.P. (AS 2002 US), 18,583 shares received by Adams Street Partnership Fund - 2003 U.S. Fund, L.P. (AS 2003 US), 14,354 shares received by Adams Street Partnership Fund - 2004 U.S. Fund, L.P. (AS 2004 US), 19,995 shares received by Adams Street Partnership Fund - 2005 U.S. Fund, L.P. (AS 2005 US), 1,186 shares received by Brinson Partnership Fund - 2004 Primary Fund, L.P. (BPF 2004 Primary), 796 shares received by The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd. (BPF 2004 Offshore), 2,472 shares received by Brinson Partnership Fund Trust - 2004 Primary Fund (BPF 2004 Trust) and 12,492 shares received by The Bank of New York Mellon as Trustee for the HP Inc. Master Trust (HP Trust), in each case, for no consideration as part of an exempt pro-rata distribution of shares on January 29, 2020 by a fund controlled by a third-party manager."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 41,587 shares held by AS 2002 US, 38,170 shares held by AS 2003 US, 29,484 shares held by AS 2004 US, 41,071 shares held by AS 2005 US, 2,436 shares held by BPF 2004 Primary, 1,635 shares held by BPF 2004 Offshore, 5,078 shares held by BPF 2004 Trust and 25,659 shares held by HP Trust. The foregoing totals reflect 21,341 shares received by AS 2002 US, 19,587 shares received by AS 2003 US, 15,130 shares received by AS 2004 US, 21,076 shares received by AS 2005 US, 1,250 shares received by BPF 2004 Primary, 839 shares received by BPF 2004 Offshore, 2,606 shares received by BPF 2004 Trust and 13,167 shares received by HP Trust, in each case, for no consideration as part of an exempt pro-rata distribution of shares on January 16, 2019 by a fund controlled by a third-party manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares owned by each of AS 2002 US, AS 2003 US, AS 2004 US, AS 2005 US, BPF 2004 Primary, BPF 2004 Offshore, BPF 2004 Trust and HP Trust (the aforementioned funds, the \"Funds\") may be deemed to be beneficially owned by Adams Street Partners, LLC, the general partner of AS 2002 US, AS 2003 US, AS 2004 US and AS 2005 US; which is the sub-advisor and acts under power of attorney with respect to BPF 2004 Primary, BPF 2004 Offshore and BPF 2004 Trust; and which is the advisor and acts under power of attorney with respect to HP Trust. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein."}],"balance_after":185120,"source":{"system":"sec-edgar","filing":"0001104659-20-021111","document":"tm207657d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920021111/tm207657d1_4.xml","form_type":"4"}},{"id":3311670,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":349806,"price":3,"value":1049418.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held directly by Adams Street Venture/Growth Fund VI LP (\"ASVG VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":1465716,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3311669,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":104942,"price":3,"value":314826.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP (\"AS 2016\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":439714,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3311668,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":120453,"price":3,"value":361359.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP (\"AS 2015\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":504708,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3311667,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":156920,"price":3,"value":470760.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Adams Street 2014 Direct Fund LP (\"AS 2014\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":711151,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3311666,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":115367,"price":3,"value":346101.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Adams Street 2013 Direct Fund LP (\"AS 2013\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":522837,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3311665,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T17:05:03.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":152512,"price":3,"value":457536.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held directly by Adams Street 2012 Direct Fund LP (\"AS 2012\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein."}],"balance_after":691176,"source":{"system":"sec-edgar","filing":"0001104659-20-003968","document":"tm203452d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920003968/tm203452d1_4.xml","form_type":"4"}},{"id":3317889,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-01-06T21:03:56.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":27829,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F10","text":"On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang , each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27829},"source":{"system":"sec-edgar","filing":"0001104659-20-001507","document":"tm201291d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465920001507/tm201291d1_4.xml","form_type":"4"}},{"id":3317888,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:03:56.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":27829,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the \"Funds\") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein."}],"balance_after":39456,"source":{"system":"sec-edgar","filing":"0001104659-20-001507","document":"tm201291d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000110465920001507/tm201291d1_4.xml","form_type":"4"}},{"id":3323310,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T16:01:19.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":4668,"price":2.142,"value":9998.856,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\").  Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer.  By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds.  Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":4668,"derivative":{"exercise_price":3.42,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":4668},"source":{"system":"sec-edgar","filing":"0001104659-20-000840","document":"tm201092d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000110465920000840/tm201092d1_4.xml","form_type":"4"}},{"id":3401143,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-02T16:01:42.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":4802,"price":2.082,"value":9997.764,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\").  Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer.  By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds.  Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":4802,"derivative":{"exercise_price":3.49,"expiration_date":"2029-09-29","underlying":"Common Stock","underlying_shares":4802},"source":{"system":"sec-edgar","filing":"0001144204-19-046946","document":"tv530461_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000114420419046946/tv530461_4.xml","form_type":"4"}},{"id":3471363,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T16:01:50.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":5046,"price":1.982,"value":10001.172,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to Elisha P. (\"Terry\") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Elisha P. Gould III is a partner of Adams Street Partners, LLC (\"Adams Street\"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein."}],"balance_after":5046,"derivative":{"exercise_price":3.34,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":5046},"source":{"system":"sec-edgar","filing":"0001144204-19-033569","document":"tv524685_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000114420419033569/tv524685_4.xml","form_type":"4"}},{"id":3479883,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-24T20:09:05.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein."}],"balance_after":15000,"derivative":{"exercise_price":3.61,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-19-032055","document":"tv524029_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000114420419032055/tv524029_4.xml","form_type":"4"}},{"id":3481071,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T20:10:31.000Z","date":"2019-06-20","kind":"other","acquired":true,"shares":3487,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the \"Series A Preferred Stock\") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Represents shares held directly by Adams Street Rimini Aggregator LLC (\"ASRA\"). Adams Street Partners, LLC, as the manager of ASRA, may be deemed to beneficially own the shares held by ASRA. David Brett, Elisha P. Gould, Sachin Tulyani and Craig D. Waslin, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by ASRA. Adams Street Partners, LLC and David Brett, Elisha P. Gould, Sachin Tulyani and Craig D. Waslin disclaim beneficial ownership of the shares held by ASRA except to the extent of their pecuniary interest therein."}],"balance_after":300514,"source":{"system":"sec-edgar","filing":"0001144204-19-031884","document":"tv523994_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000114420419031884/tv523994_4.xml","form_type":"4"}},{"id":3481070,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T20:10:31.000Z","date":"2019-06-20","kind":"other","acquired":true,"shares":417,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the \"Series A Preferred Stock\") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by Adams Street 2009 Direct Fund, L.P. (\"AS 2009\"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2009, may be deemed to beneficially own the shares held by AS 2009. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2009. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2009 except to the extent of their pecuniary interest therein."}],"balance_after":4307978,"source":{"system":"sec-edgar","filing":"0001144204-19-031884","document":"tv523994_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000114420419031884/tv523994_4.xml","form_type":"4"}},{"id":3481069,"issuer":{"id":5475,"kind":"organization","name":"Rimini Street, Inc.","symbol":"RMNI"},"owners":[{"id":78834,"kind":"organization","name":"ADAMS STREET PARTNERS LLC","position":1,"cik":"0001193586","reported_name":"ADAMS STREET PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T20:10:31.000Z","date":"2019-06-20","kind":"other","acquired":true,"shares":476,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the \"Series A Preferred Stock\") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by Adams Street 2008 Direct Fund, L.P. (\"AS 2008\"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2008, may be deemed to beneficially own the shares held by AS 2008. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2008. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2008 except to the extent of their pecuniary interest therein."}],"balance_after":4916957,"source":{"system":"sec-edgar","filing":"0001144204-19-031884","document":"tv523994_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193586/000114420419031884/tv523994_4.xml","form_type":"4"}}],"next_cursor":"2019-06-21T20:10:31.000000Z,3481069"}